Characterization, Monitoring, and Control of Bacterial Biofilms

Bacterial biofilms which grows and react to the surrounding. It pays particular attention to determining their structural elements, microbial structure, and functional characteristics. Gram-negative bacteria such as Pseudomonas aeruginosa, Escherichia coli, and Klebsiella pneumoniae biofilms which harbor lipopolysaccharides (LPS) in their outer membrane and Gram-positive bacteria like Staphylococcus aureus, Streptococcus mutans and Enterococcus faecalis biofilms that have thick peptidoglycan layers and strong EPS. The process of monitoring and characterizing biofilm involves biofilm development and activity as well as preventing biofilms or eliminating biofilms through physical, chemical or biological means. The processes play a vital role in controlling biofilm-related problems in the healthcare, industry, and environmental systems. Bacterial biofilms are structured communities of microbial cells enclosed in a self-produced extracellular polymeric substance (EPS) matrix and attached to surfaces. They play crucial roles in environmental, industrial, and clinical contexts, contributing to persistent infections, biofouling, and contamination. This chapter reviews the formation, structural and molecular characterization, monitoring techniques, resistance mechanisms, and strategies for biofilm control.

Keywords:  Bacterial Biofilm, Mechanism, Inhibition

1. Introduction

Bacterial biofilms represent a ubiquitous mode of microbial life, with ecological and clinical significance. Unlike planktonic cells, biofilm-associated bacteria exhibit altered physiology, enhanced resistance to antimicrobials, and persistent survival(38). They are found in natural environments (rivers, soil, marine habitats), industrial systems (pipelines, food processing equipment), and medical settings (implants, chronic wounds). The economic and public health impacts of biofilms are substantial, including increased treatment costs, device failure, and waterborne disease outbreaks.

Bacterial biofilms are organized layers of bacteria which attach to surfaces by a self-produced extra cellular polymeric medium (EPS) which transforms bacterial physiology and ecological approach in comparison with free living (planktonic) cells. Biofilms are widespread in nature, industry and the clinic and form the most common form of life on earth. In contrast to the planktonic bacteria, which swim freely in the liquid medium, the biofilm cells lead sessile lifestyle enabling them to colonize surfaces, cooperate and survive in the adverse conditions (EPS and community traits)

The biofilm is a complex structure attached microorganisms with surfaces not mere aggregates but structured entities with emergent characteristics. The complex three dimensional architecture found in these communities has been compared to microbes because of organized microcolonies and fluid filled channels which transport nutrients and waste through the matrix (29).

Biofilms have a characteristic EPS matrix which is mainly composed of polysaccharides, proteins, lipids and extracellular DNA (eDNA) which offers them mechanical stability, structural cohesiveness and resistance to environmental factors and antimicrobial factors (28).

The formation of biofilm is the process of development that is regulated and induced by environmental signals through cell to cell communication (quorum sensing). The traditional steps of biofilm development are reversible attachment, irreversible attachment, microcolony development, maturation of biofilm, and final dispersion of cells to the environment so as to penetrate new niches. This lifecycle is a dynamic equilibrium between the adherence of the surface and the exploration of the environment (34). The effects of biofilm formation on the antibiotic tolerance and resistance are one of the most significant consequences of biofilm formation. Biofilm bacteria are exceptionally resistant to antimicrobial compounds relative to planktonic bacteria and it has been observed that biofilm cells can withstand antibiotic exposures that are many times greater than those of planktonic cells. This increased tolerance is due to several factors: the EPS matrix prevents penetration of the antibiotics, heterogeneity of the metabolism inside the biofilm makes the drugs intolerable to actively dividing cells and finally, strong proximity to cells makes horizontal gene transfer of the resistance determinants easier. These properties predispose biofilm associated infections, which is hard to eliminate and leads to chronic and recurrent disease conditions (antimicrobial tolerance mechanisms) (30).

Biofilms most relevant in clinical medicine as they are associated with chronic and infections that are difficult to cure such as chronic and device related infections, including catheter, prosthetic joints, and endotracheal tube ones, are linked to bacteria biofilms. In addition to preventing the effects of antibiotics, the matrix also shields the microbial communities against the effects of the host immune system, enabling them to evade phagocytosis and complement action and survive within host tissues. In such environments biofilms can be polymicrobial consortia, which enhances pathogenic potential due to the synergistic effects and common resistance mechanisms (21).

Not all biofilms are harmful. The ecological and biotechnological roles of biofilm formation are of importance in the environmental and industrial settings. Biofilm microbial consortia are effective in treating wastewater and bioremediation of organic pollutants. Some natural ecosystems like plant roots, riverbeds and soils, have biofilms that facilitate nutrient cycling and also shape microbial ecology. But in industrial applications, biofilms tend to be an issue, causing biofouling, corrosion and loss of efficiency in pipelines, heat exchangers and food processing equipment. The capacity of biofilms to create robust communities on biotic and abiotic surfaces creates continuous problems to maintenance, sanitation, and product safety (37). 

The EPS matrix has multidimensional functions at a mechanistic level other than physical. Extracellular polymers facilitate surface adhesion through electrostatic and hydrophobic interactions, offer diffusion barrier that retards diffusion of antibiotics and host antimicrobials and form microenvironment with chemical gradient that induces gene expression and metabolic conditions within the community. These gradients cause heterogeneous conditions with cells in the deeper layers being frequently slow growing or dormant, which also causes antibiotic tolerance as many antimicrobials act on active metabolic processes. It is the complexity of biofilms in structure that is therefore as a consequence of biochemical makeup and emergent spatial arrangement (EPS functions and biofilm architecture) (36).

Biofilms are also able to adapt to evolve with evolutionary time to maximize their communal existence. There is evidence to indicate that a large number of bacteria possess genetic determinants committed to the formation of biofilm that gives them an evolutionary edge in dynamic or adverse conditions. Biofilm formation promotes community-based horizontal gene transfer and genetic diversification, which leads to adaptation and resilience. These evolutionary views support the reason why biofilms are an ancient and effective system of surviving by microorganisms long before the appearance of multicellular eukaryotes and continue to be found in a multitude of environments ranging deep waters to surfaces of human tissues (31).

New technologies like microfluidics, modern imaging, and molecular profiling are broadening our knowledge of the behavior of biofilms on a spatial and temporal scale which was previously not available. Such interdisciplinary studies can possibly come up with more efficient methods to control biofilms in clinical and industrial environments as well as utilize their positive effect in bio-process and environmental remediation (20).